IBDEI0GF ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7976,1,4,0)
 ;;=4^374.46
 ;;^UTILITY(U,$J,358.3,7976,2)
 ;;=^15279
 ;;^UTILITY(U,$J,358.3,7977,0)
 ;;=374.50^^58^604^30
 ;;^UTILITY(U,$J,358.3,7977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7977,1,3,0)
 ;;=3^Eyelid Degen D/O,Unspec
 ;;^UTILITY(U,$J,358.3,7977,1,4,0)
 ;;=4^374.50
 ;;^UTILITY(U,$J,358.3,7977,2)
 ;;=^269106
 ;;^UTILITY(U,$J,358.3,7978,0)
 ;;=374.52^^58^604^34
 ;;^UTILITY(U,$J,358.3,7978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7978,1,3,0)
 ;;=3^Eyelid Hyperpigmentation
 ;;^UTILITY(U,$J,358.3,7978,1,4,0)
 ;;=4^374.52
 ;;^UTILITY(U,$J,358.3,7978,2)
 ;;=^269108
 ;;^UTILITY(U,$J,358.3,7979,0)
 ;;=374.53^^58^604^36
 ;;^UTILITY(U,$J,358.3,7979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7979,1,3,0)
 ;;=3^Eyelid Hypopigmentation
 ;;^UTILITY(U,$J,358.3,7979,1,4,0)
 ;;=4^374.53
 ;;^UTILITY(U,$J,358.3,7979,2)
 ;;=^269109
 ;;^UTILITY(U,$J,358.3,7980,0)
 ;;=374.54^^58^604^35
 ;;^UTILITY(U,$J,358.3,7980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7980,1,3,0)
 ;;=3^Eyelid Hypertrichosis
 ;;^UTILITY(U,$J,358.3,7980,1,4,0)
 ;;=4^374.54
 ;;^UTILITY(U,$J,358.3,7980,2)
 ;;=^269111
 ;;^UTILITY(U,$J,358.3,7981,0)
 ;;=374.56^^58^604^39
 ;;^UTILITY(U,$J,358.3,7981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7981,1,3,0)
 ;;=3^Eyelid Oth Degenerative Skin D/O
 ;;^UTILITY(U,$J,358.3,7981,1,4,0)
 ;;=4^374.56
 ;;^UTILITY(U,$J,358.3,7981,2)
 ;;=^269114
 ;;^UTILITY(U,$J,358.3,7982,0)
 ;;=374.81^^58^604^33
 ;;^UTILITY(U,$J,358.3,7982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7982,1,3,0)
 ;;=3^Eyelid Hemorrhage
 ;;^UTILITY(U,$J,358.3,7982,1,4,0)
 ;;=4^374.81
 ;;^UTILITY(U,$J,358.3,7982,2)
 ;;=^269115
 ;;^UTILITY(U,$J,358.3,7983,0)
 ;;=374.82^^58^604^32
 ;;^UTILITY(U,$J,358.3,7983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7983,1,3,0)
 ;;=3^Eyelid Edema
 ;;^UTILITY(U,$J,358.3,7983,1,4,0)
 ;;=4^374.82
 ;;^UTILITY(U,$J,358.3,7983,2)
 ;;=^276852
 ;;^UTILITY(U,$J,358.3,7984,0)
 ;;=374.85^^58^604^45
 ;;^UTILITY(U,$J,358.3,7984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7984,1,3,0)
 ;;=3^Eyelid Vascular Anomalies
 ;;^UTILITY(U,$J,358.3,7984,1,4,0)
 ;;=4^374.85
 ;;^UTILITY(U,$J,358.3,7984,2)
 ;;=^269120
 ;;^UTILITY(U,$J,358.3,7985,0)
 ;;=374.86^^58^604^38
 ;;^UTILITY(U,$J,358.3,7985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7985,1,3,0)
 ;;=3^Eyelid Oth D/O,Floppy Eyelid Synd
 ;;^UTILITY(U,$J,358.3,7985,1,4,0)
 ;;=4^374.86
 ;;^UTILITY(U,$J,358.3,7985,2)
 ;;=^269121
 ;;^UTILITY(U,$J,358.3,7986,0)
 ;;=376.11^^58^604^89
 ;;^UTILITY(U,$J,358.3,7986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7986,1,3,0)
 ;;=3^Orbit Granuloma/Pseudotumor
 ;;^UTILITY(U,$J,358.3,7986,1,4,0)
 ;;=4^376.11
 ;;^UTILITY(U,$J,358.3,7986,2)
 ;;=^269176
 ;;^UTILITY(U,$J,358.3,7987,0)
 ;;=376.21^^58^604^93
 ;;^UTILITY(U,$J,358.3,7987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7987,1,3,0)
 ;;=3^Orbit Thyrotoxic Exophthalmos
 ;;^UTILITY(U,$J,358.3,7987,1,4,0)
 ;;=4^376.21
 ;;^UTILITY(U,$J,358.3,7987,2)
 ;;=^269181
 ;;^UTILITY(U,$J,358.3,7988,0)
 ;;=376.33^^58^604^83
 ;;^UTILITY(U,$J,358.3,7988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7988,1,3,0)
 ;;=3^Orbit Edema
 ;;^UTILITY(U,$J,358.3,7988,1,4,0)
 ;;=4^376.33
 ;;^UTILITY(U,$J,358.3,7988,2)
 ;;=^269186
 ;;^UTILITY(U,$J,358.3,7989,0)
 ;;=376.40^^58^604^82
 ;;^UTILITY(U,$J,358.3,7989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7989,1,3,0)
 ;;=3^Orbit Deformity,Unspec
 ;;^UTILITY(U,$J,358.3,7989,1,4,0)
 ;;=4^376.40
 ;;^UTILITY(U,$J,358.3,7989,2)
 ;;=^269191
 ;;^UTILITY(U,$J,358.3,7990,0)
 ;;=376.41^^58^604^90
 ;;^UTILITY(U,$J,358.3,7990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7990,1,3,0)
 ;;=3^Orbit Hypertelorism
